Observation on the clinical efficacy of ' Qushi Qingti ' acupoint application in the treatment of simple obesity of phlegm-dampness type

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300076827

Enrollment

Unknown

Registered

2023-10-20

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Simple obesity

Interventions

Treatment group:Basic treatment + ''Qushi Qingti'' acupoint application

Control group:Basic treatment +Placebo acupoint application with a concentration of 1/10 of the "Qushi Qingti"

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ( 1 ) Exclude secondary obesity and meet the diagnostic criteria of simple obesity of phlegm-dampness type in traditional Chinese medicine and western medicine ; ( 2 ) 18 to 65 years old ; gender unlimited ; ( 3 ) In the past 2 months did not participate in other weight loss related treatment ; ( 4 ) Obtain informed consent, voluntarily accept the treatment, and provide follow-up observers.

Exclusion criteria

Exclusion criteria: ( 1 ) Patients with severe liver and kidney dysfunction, cardiopulmonary dysfunction, hypothyroidism, malignant tumor ; ( 2 ) Poor control of severe hypertension, that is, systolic blood pressure = 180mmHg and / or diastolic blood pressure = 110mmHg ; patients with systolic blood pressure < 95mmHg ; ( 3 ) The existence of mental disorders, language barriers, leading to the inability to fully understand the research program or with the researchers ; ( 4 ) Diagnosed with obesity caused by Cushing 's syndrome, drugs, thyroid, adrenal gland, gonad, hypothalamus, pituitary or other endocrine system diseases ; ( 5 ) Take hypoglycemic drugs, lipid-lowering drugs ( such as statins, fibrates, etc. ), weight loss drugs, hepatoprotective drugs, glucocorticoids and drugs that may affect the monitoring of blood glucose, blood lipids, islet function and other indicators in the past 4 weeks ; ( 6 ) Have undergone bariatric surgery or are participating in other weight loss programs or have lost more than 5 % of their body weight in the past 6 months ; ( 7 ) Have a history of alcoholism, male drinking alcohol content = 140g per week, female = 70g ; ( 8 ) Women who are pregnant or in lactation.

Design outcomes

Primary

Measure	Time frame
Body Weight;Waistline;Hipline;Body Fat Percentage;	—

Secondary

Measure	Time frame
Total Cholesterol;Serum Triglyceride;Fasting Blood Glucose;Serum Insulin Level;C-peptide Levels;Serum Uric Acid;	—

Countries

China

Contacts

Public ContactFeiHuang

Suzhou Traditional Chinese Medicine Hospital

szhuangfei@126.com+86 130 9260 5344

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026